Martine A Rothblatt United Therapeutics Corp (UTHR) insider trading activity

Martine A Rothblatt is Chairperson & CEO of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 130 shares of UTHR, which is worth approximately $60,632. The most recent transaction as insider was on Sep 23, 2025, when has been sold 4,000 shares (Common Stock) at a price of $120.26 per share, resulting in proceeds of $481,040. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 130

0% 3M change

0% 12M change

Total Value Held $60,632

MARTINE A ROTHBLATT Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 23 2025	BUY Exercise of conversion of derivative security	$481,040 $120.26 p/Share	4,000 Added 49.2%	4,130 Common Stock
Sep 22 2025	SELL Open market or private sale	$1,669,240 $417.31 p/Share	4,000 Reduced 96.85%	130 Common Stock
Sep 22 2025	BUY Exercise of conversion of derivative security	$481,040 $120.26 p/Share	4,000 Added 49.2%	4,130 Common Stock
Sep 19 2025	SELL Open market or private sale	$1,644,320 $411.08 p/Share	4,000 Reduced 96.85%	130 Common Stock
Sep 19 2025	BUY Exercise of conversion of derivative security	$481,040 $120.26 p/Share	4,000 Added 49.2%	4,130 Common Stock
Sep 18 2025	SELL Open market or private sale	$1,619,360 $404.84 p/Share	4,000 Reduced 96.85%	130 Common Stock
Sep 18 2025	BUY Exercise of conversion of derivative security	$481,040 $120.26 p/Share	4,000 Added 49.2%	4,130 Common Stock

Sep 17 2025	SELL Open market or private sale	$1,601,720 $400.43 p/Share	4,000 Reduced 96.85%	130 Common Stock
Sep 17 2025	BUY Exercise of conversion of derivative security	$481,040 $120.26 p/Share	4,000 Added 49.2%	4,130 Common Stock
Sep 16 2025	SELL Open market or private sale	$1,599,720 $399.93 p/Share	4,000 Reduced 96.85%	130 Common Stock
Sep 16 2025	BUY Exercise of conversion of derivative security	$481,040 $120.26 p/Share	4,000 Added 49.2%	4,130 Common Stock
Sep 15 2025	SELL Open market or private sale	$1,591,800 $397.95 p/Share	4,000 Reduced 96.85%	130 Common Stock
Sep 15 2025	BUY Exercise of conversion of derivative security	$481,040 $120.26 p/Share	4,000 Added 49.2%	4,130 Common Stock
Sep 12 2025	SELL Open market or private sale	$1,614,680 $403.67 p/Share	4,000 Reduced 96.85%	130 Common Stock
Sep 12 2025	BUY Exercise of conversion of derivative security	$481,040 $120.26 p/Share	4,000 Added 49.2%	4,130 Common Stock
Sep 11 2025	SELL Open market or private sale	$1,588,920 $397.23 p/Share	4,000 Reduced 96.85%	130 Common Stock
Sep 11 2025	BUY Exercise of conversion of derivative security	$481,040 $120.26 p/Share	4,000 Added 49.2%	4,130 Common Stock
Sep 10 2025	SELL Open market or private sale	$1,594,880 $398.72 p/Share	4,000 Reduced 96.85%	130 Common Stock
Sep 10 2025	BUY Exercise of conversion of derivative security	$481,040 $120.26 p/Share	4,000 Added 49.2%	4,130 Common Stock
Sep 09 2025	SELL Open market or private sale	$3,190,880 $398.86 p/Share	8,000 Reduced 98.4%	130 Common Stock
Sep 09 2025	BUY Exercise of conversion of derivative security	$962,080 $120.26 p/Share	8,000 Added 49.6%	8,130 Common Stock
Aug 26 2024	SELL Open market or private sale	$93,848 $348.88 p/Share	269 Reduced 67.42%	130 Common Stock
Aug 26 2024	BUY Exercise of conversion of derivative security	$34,832 $129.49 p/Share	269 Added 40.27%	399 Common Stock
Aug 23 2024	SELL Open market or private sale	$1,250,928 $347.48 p/Share	3,600 Reduced 96.51%	130 Common Stock
Aug 23 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock

MAR

Martine A Rothblatt

Chairperson & CEO

Silver Spring, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Value

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

Operation

Value

Type

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR

Account